Really, wow. This isn't even an example with a company that started out with a miniscule market cap and was still small after skyrocketing. The current market cap for Novavax is U.S.$17.5 billion.
Look at how much it has grown in the last year:
If Mesoblast had a market cap of 17.5 billion U.S.$, then Meso would be almost at $135 and MSB would be almost $35. Novavax was almost $24 billion at the peak. That would be about $185 for Meso and over $47 for MSB. No wonder the shorts are scared.
Ann: COVID ARDS Trial Topline 60-Day Results, page-304
-
- There are more pages in this discussion • 1,325 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.39 |
Change
-0.005(0.36%) |
Mkt cap ! $1.581B | |||
| Open | High | Low | Value | Volume |
| $1.40 | $1.42 | $1.38 | $4.391M | 3.156M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 48253 | $1.39 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.40 | 32922 | 2 |
View Market Depth
| Last trade - 16.10pm 10/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |